CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest

• Private equity firms have approached Conmed with acquisition interest.
• Conmed develops and manufactures surgical devices and equipment focused on orthopedic and general surgery.
• Conmed is currently sharpening its focus on higher-margin core surgical segments.

Conmed Corporation (CNMD) shares jumped as much as 10% in after-hours trading on Friday after reports that the company is weighing a potential sale following takeover interest from private equity firms.

The medical technology company is working with advisers to evaluate strategic options, Bloomberg Law reported, citing people familiar with the matter.

Takeover Interest

Private equity firms have approached Conmed with acquisition interest. While no formal sale process has been confirmed, the company is actively reviewing its alternatives. Specific bidders have not been publicly disclosed.

Company Background

Conmed develops and manufactures surgical devices and equipment focused on orthopedic and general surgery. Its key products include sports medicine implants, powered instruments, electrosurgery systems and the AirSeal insufflation platform.

Conmed has faced notable near-term challenges. The company’s exit from its gastroenterology product lines, completed in early 2026, reduced first quarter (Q1) revenue by around $15.5 million and is expected to dilute 2026 adjusted earnings per share by $0.45–$0.50.

Conmed reported Q1 revenue of $317 million, down 1.3% year-over-year but up 2.1% organically on a constant-currency basis. Adjusted EPS fell 6.3% to $0.89.

To improve performance, Conmed is sharpening its focus on higher-margin platforms, particularly orthopedics, AirSeal, Buffalo Filter, and BioBrace products.

How Did Retail Traders React?

On Stocktwits, retail sentiment around CNMD stock fell from ‘bearish’ to ‘extremely bearish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.

A Stocktwits user speculated how much the company would garner in a buyout.

Another user dismissed the buyout report as a rumor.

CNMD stock has fallen 5% year-to-date. 

Read More: MGM Stock Edges Up After-Hours On Barry Diller’s $12.4B Buyout Offer

For updates and corrections, email newsroom[at]stocktwits[dot]com.